CN101142947A - Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method - Google Patents
Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method Download PDFInfo
- Publication number
- CN101142947A CN101142947A CNA2007100357964A CN200710035796A CN101142947A CN 101142947 A CN101142947 A CN 101142947A CN A2007100357964 A CNA2007100357964 A CN A2007100357964A CN 200710035796 A CN200710035796 A CN 200710035796A CN 101142947 A CN101142947 A CN 101142947A
- Authority
- CN
- China
- Prior art keywords
- oil
- dha
- epa
- fish
- refining
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention provides nutritional blend oil containing fish oil or polyene fish oil. The blend oil adopts refined peanut oil, double-low rapeseed oil and other plant oil as raw material, fish oil and polyene fish oil is taken as mixing oil, and antioxidant agent consists of lipo-soluble tea polyphenol and vitamin E. Addition is calculated according to physical and nutritional requirement of various population and the content of various fatty acid in raw oil and mixing oil. Every 100g of product blend oil contains SFA 12-18g, MUFA 39-46g, omega-6 PUFA 31-38g and omega-3 PUFA 5-9g, wherein, total amount of omega-3 LCPUFA DHA+DPA+EPA is 0.1-5.0g, the ratio of DHA and (DPA+EPA) is 0.25-10:1, and the ratio of DHA and EPA is 4:1-25:1. The blend oil has the effect of promoting brain development, preventing myopia and early-aged dementia and reducing the occurrence of cardiovascular and cerebrovascular diseases, etc.
Description
Technical field
The present invention relates to a kind of edible blend oil that contains additive, particularly a kind of nutrient blend oil and preparation method thereof.
Background technology
For a long time, China's vegetable fat health care is not subjected to enough attention always, the not rational allocation of various fatty acid compositions.The intake of aliphatic acid in the relevant meals, the World Health Organization and FAO's suggestion, the aliphatic acid of human body absorption every day is saturated fatty acid (SFA) with the ratio of three kinds of aliphatic acid: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=be advisable at 1: 1: 1.And the first two plants fully then a kind of undersupply of fatty acid supplying in the present edible oil of China, but polyunsaturated fatty acid role in human body still is important, as ω-6 is that linoleic acid and ω-3 are the eicosenoic acids such as prostaglandin, leukotriene and thromboxane that alpha-linolenic acid can generate different series, important biomolecule chemical processes such as the formation of immunological regulation in the participation body, inflammatory reaction and thrombus and dissolving produce significant effects to health.ω-6 is that linoleic acid also can generate the maximum arachidonic acid (AA) of content in the brain (phosphatide) by prolonging carbochain and desaturation effect in human body, and ω-3 to be alpha-linolenic acid can generate maximum DHA (DHA) of content in brain (phosphatide) and the retina and eicosapentaenoic acid (EPA) by prolonging carbochain and taking off full effect in human body.ω-6 such as above-mentioned AA, EPA, DHA are and the long carbochain of ω-3 is that polyunsaturated fatty acid all is the indispensable essential fatty acid of human body, are called as long-chain polyunsaturated fatty acid (LCPUFA).Though being linoleic acid, ω-6 can synthesize AA (arachidonic acid) in vivo, ω-3 is that alpha-linolenic acid can synthesize EPA (acid of peanut pentaene) in vivo, DHA, but human body need use with a series of enzymes when utilizing synthetic isonomic other polyunsaturated fatty acid of above-mentioned two kinds of essential fatty acids, because competitive inhibitory effect, aggregate velocity is slow in vivo to make it, its synthetic quantity can not satisfy the Human Physiology needs, because omega-3 unsaturated fatty acid (ω-3PUFA) lack by the half-life, only about 10h, can not accumulate the essential directly additional above-mentioned polyunsaturated fatty acid of old friend's body in the body.Therefore, it is that linoleic acid and ω-3 are alpha-linolenic acid that human body not only needs to provide the ω-6 as synthesis material, also will replenish ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) every day.
ω-6 is that linoleic acid can obtain from various plants oil, ω-3 is that alpha-linolenic acid can obtain from linseed oil, soybean oil, Canola Oil, Purple Perilla Seed Oil, content is seldom in edible oil for the oil of above-mentioned kind in the prior art, therefore oil with common edible supply ω-3 is the aliphatic acid deficiency, especially lack ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA), people can only replenish by edible all kinds of health products, as edible deep-sea fish oil soft capsules, fish oil soft capsule etc.But consumers in general lack relevant nutrition professional knowledge, can not correctly replenish, and forget easily and take, supply that can not continuous and effective, so both strengthened people's life cost, be difficult to again obtain the balanced nutrients composition, do not reach wholesome purpose, how correctly to replenish is a difficult problem of exploring.(ω-3LCPUFA) is an approach that economically feasible is convenient and practical to replenish ω-3 long-chain polyunsaturated fatty acid in the human body by edible oil.
To correctly replenish grease, should reach following requirement: 1, the aliphatic acid of taking in every day is saturated fatty acid (SFA) with the ratio of three kinds of aliphatic acid: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=1: 1: 1, the ratio of linoleic acid and the content of alpha-linolenic acid is to be advisable at 4～6: 1, mainly is that ω-6 as synthesis material is that linoleic acid and ω-3 are that alpha-linolenic acid supplies with should be abundant.2, ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) also needs directly replenish every day except that synthetic in human body.3, according to the different needs amount of different crowd to DHA, EPA, make DHA, EPA ratio in ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) of its acquisition meet himself needs, avoid wherein a certain not enough or excessive, when effectively replenishing, avoid it to have side effects.For this reason, those skilled in the art has done useful trial.Chinese patent CN1483336A disclosed " balanced nutrients ready-mixed oil ", it has stipulated that the ratio of the content of monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) is 1: 1, linoleic acid is 4～6: 1 with the ratio of the content of alpha-linolenic acid, but do not consider the ratio of saturated fatty acid, directly do not add ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) yet; Chinese patent CN1448061A discloses the production method of golden imperial fish second generation nutrient blend oil, though it has considered saturated fatty acid (SFA), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) ratio, considered that also ω-6 is that aliphatic acid linoleic acid and ω-3 are the content ratio of aliphatic acid alpha-linolenic acid, but there is following defective in it: 1, directly do not add ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA), the long-chain omega-3 polyunsaturated fatty acids of needed by human body (ω-3 LCPUFA) is that leukotrienes transforms in human body and gets by ω-3 only, can not satisfy the human body needs.2, the grease of heterogeneity and proportioning is not provided at the crowd demand of all ages and classes stage and health status.In order to replenish ω-3 is aliphatic acid, and its technical scheme that adopts is the proportion that increases rapeseed oil, and its shared percentage by weight reaches 20～65%, is its Main Ingredients and Appearance, is the purpose of aliphatic acid though this patent has realized additional ω-3, because of rapeseed oil contains erucic acid, promptly along Δ
1322 carbon monoenoic acids, it is a kind of long-chain monounsaturated fatty acids, its carbochain is than the sour four carbon atom that manys of common fats.Erucic acid has no adverse effects for the normal human of health, contains a kind of enzyme that digests erucic acid that decomposes in the human body, and it can destroy the erucic acid of picked-up, is absorbed by the body to enter blood after digestion.Under the cardiovascular function normal condition, it can not cause in the human body the especially fat accumulation of cardiovascular system of some organ, brings out pathology.But for the cardiac, but there is the possibility that causes " myocardium fat deposition ", show according to investigations, the phenomenon of " the myocardium fat deposition " that causes owing to edible rapeseed oil accounts for whole cardiac's 4/5, the U.S. once found from 100 routine cardiac's corpse of dissecting, the erucic acid that truly has in " cardiac muscle fat " exists, and content reaches more than 5.6%.Because accept on a small quantity by behind the erucic acid after the enzymic digestion every day in cardiac's the blood, abnormal cardiovascular function will excess load originally, and easier bringing out " vessel wall thickening " reaches " myocardium fat deposition ", directly endangers healthy.Therefore, it is edible that the ratio of golden imperial fish second generation nutrient blend oil is not suitable for the cardiovascular and cerebrovascular patient.Improving ω-3 by the ratio that increases rapeseed oil is that content of fatty acid does not have general applicability, does not have the consumer under the prerequisite of relevant nutrient knowledge and can cause adverse effect to the cardiovascular and cerebrovascular diseases people.3, key component in this oil---soybean oil and rapeseed oil are the transgenosis grease.Whether GM food especially exists potential hazard not prove through long-term practice to fetus, baby, child, children and adolescent growth growth to human body.
Chinese patent application CN1398532A disclosed " a kind of preparation method of functional olive oil concentrating agent ", Chinese patent application CN1398533A disclosed " a kind of functional high-grade cooking olive oil and preparation method thereof ", Chinese patent application CN1191677A " a kind of functional natural edible oil " is though added deep sea fish oil in the prescription, but there is following problem in above-mentioned patent application: 1, do not consider fatty acid total amount and form the requirement whether meet the human nutrition equilibrium that the aliphatic acid of taking in every day with human body is not saturated fatty acid (SFA) with the ratio of three kinds of aliphatic acid: monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=1: 1: 1 be a prerequisite interpolation deep sea fish oil; 2, do not mention and do not set forth main active DHA in the deep sea fish oil, EPA physiology and health-care effect yet, more do not analyze the content of DHA and EPA in the deep sea fish oil, must cause that to replenish the indeterminate and additional dosage of purpose inaccurate.In actual applications, because manufacturer is different with specification, ω in the fish oil-3 long-chain polyunsaturated fatty acid DHA is also different with content and the proportioning thereof of EPA, and DHA and the EPA content according to accurate Calculation does not add deep sea fish oil, must cause magnitude of recruitment inaccurate, phenomenon on the low side or higher occur; The physiological requirements of not satisfying human body on the low side, excessive absorption then can be because of the unsaturated double-bond generation peroxidization in its structure, produce lipid peroxide, this is a kind of free radical, be one of hazards that promote old and feeble and generation cancer, body is produced multiple chronic hazard, if come across skin, then form lipofuscin and senile plaque expelling occurs as this lipid peroxide; If come across in the cell, cell function is weakened; The unrighted acid of adiposis patient Excessive Intake easily causes cholelithiasis; Studies have shown that the rising of lipid peroxide is bigger to atherosclerotic formation harm than the rising of cholesterol in the blood.3, DHA that is added and EPA weight ratio science not can not satisfy the physiological requirements of different edible objects.EPA can be metabolized to prostacyclin in human body, and then the body sexual function, as the excessive EPA of children taking, the possibility that promotes sex premature is arranged, the inhibition that EPA also has children's intelligence and skeleton development.DHA is easy to enter brain cell by the brain barrier, is present in brain cell and the brain cell projection, and children's excessive use will cause nerve to be overexcited.Therefore, DHA and EPA content proportioning be science not, also can cause the influence healthy to some crowd.Though 4, above-mentioned three kinds of prescription edible oils have added the deep sea fish oil that contains ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA), add heat stabilization test, after culinary art heating process, can keep how many compositions also for unknown.
1978, physician Du Ribeige finds in epidemiological survey, the Eskimos is the incidence of disease very low (having only Danish 1/10) of coronary heart disease, miocardial infarction not only, and autoimmune disease such as rheumatoid arthritis, lupus erythematosus also is starkly lower than white people.Think that ocean fish, the sea dog in the edible Arctic Ocean have important relationship in a large number for this and Eskimos.Fish oil is the aliphatic acid that extracts from deep water ocean fish classes such as salmon, long tail anchovy, sardine, tuna, and polyenoid fish oil is triglyceride type, ethyl ester type or other esterification products after the pyloric fat acid processing.Fish oil and polyenoid fish oil are rich in eicosapentaenoic acid (EPA) and DHA long-chain omega-3 polyunsaturated fatty acidses such as (DHA), are the essential fatty ester acid of keeping human development, growth and normal physiological function.At present, can produce the fish oil and the polyenoid fish oil of DHA+EPA total content 10～80%, DHA and EPA different content proportioning through process for refining such as multiple-grade molecular distillation equipment.
Because the health-care efficacy of fish oil and polyenoid fish, it has been made into various forms of health products and has sold on market.The suitable grease of screening from each vegetable oil, the fish oil of reasonable dosage and the ratio of arranging in pairs or groups or polyenoid fish oil additive, replenish ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) of needed by human body by edible oil, for different crowd provides the nutrient blend oil of different cultivars, be an approach that economically feasible is convenient and practical.
Summary of the invention
The objective of the invention is to overcome the deficiency of prior art, fish oil or polyenoid fish oil are joined in the edible oil, make edible oil have health care, and realization suitability for industrialized production, for all ages and classes and type crowd provide dissimilar nutrient blend oils, to satisfy it to variety classes aliphatic acid and to the needs of DHA, EPA.
Technical scheme of the present invention is:
A kind of nutrient blend oil, it is characterized in that: it is to add fish oil or polyenoid fish oil and make in vegetable fat, the addition of described fish oil or polyenoid fish oil is to decide according to the total content of its contained ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA), be 0.1～5.0g modulation by containing ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) total amount in every 100g finished product ready-mixed oil behind interpolation fish oil or the polyenoid fish oil promptly, described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is the combination of DHA (DHA) and eicosapentaenoic acid (EPA).
As to further improvement of the present invention, described vegetable fat consists of in the two low rapeseed oils of refine peanut oil, refining sunflower oil, refining, purified soyabean oil, refined sesame oil, refining linseed oil, refined maize's oil, refining Purple Perilla Seed Oil, refining walnut oil, refining tea-seed oil, refining safflower seed oil, the refined olive oil four or more combination, and the incorporation in the finished product ready-mixed oil of every 100g is:
Refine peanut oil 19～44g refining sunflower oil 0～27g
The two low rapeseed oil 0～40g purified soyabean oil 0～35g of refining
Refined sesame oil 0～5g refining linseed oil 0～10.7g
Oil 0～the 28g of refined maize refining Purple Perilla Seed Oil 0～8g
Refining walnut oil 0～5g refining tea-seed oil 0～24g
Refining safflower seed oil 0～5g refined olive oil 0～8g.
As to further improvement of the present invention, in the children and youth auxotype, described DHA (DHA) is DHA: EPA=4.0 with eicosapentaenoic acid (EPA) weight ratio R: 1～10.0: 1.
As to further improvement of the present invention, in the pregnant nursling children auxotype, described DHA (DHA) is DHA: EPA=10 with the weight ratio R of eicosapentaenoic acid (EPA): 1～25: 1.
As to further improvement of the present invention, during household economy was practical, the weight ratio R of described DHA (DHA), eicosapentaenoic acid (EPA) was DHA: EPA=0.7: 1～2: 1.
As to further improvement of the present invention, in the cardiovascular health-care function type, described DHA (DHA) is DHA: EPA=0.25 with the weight ratio R of eicosapentaenoic acid (EPA): 1～0.7: 1, and described vegetable fat consists of the combination more than four kinds and four kinds in refine peanut oil, refining sunflower oil, purified soyabean oil, refined sesame oil, refining linseed oil, refined maize's oil, refining Purple Perilla Seed Oil, refining walnut oil, refining tea-seed oil, refining safflower seed oil, the refined olive oil.
As to further improvement of the present invention, it is characterized in that: added antioxidant in the described vegetable fat, described antioxidant is fat-soluble tea polyphenol or vitamin E.
As to further improvement of the present invention, it is characterized in that: described antioxidant is a fat-soluble tea polyphenol, and addition is to contain 0.002～0.03g in every 100g finished product ready-mixed oil.
As to further improvement of the present invention, it is characterized in that: described antioxidant is a vitamin E, and addition is to contain 0.01～0.2g in every 100g finished product ready-mixed oil.
A kind of production method of nutrient blend oil is characterized in that comprising the steps:
(1) selected needed raw material edible oil;
(2) according to the total amount of finished product ready-mixed oil required ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) and the fish oil or the polyenoid fish oil of the selected required interpolation of the requirement of the weight ratio between DHA, the EPA thereof;
(3) calculate fish oil or the addition of polyenoid fish oil and the weight ratio between DHA, the EPA thereof according to following relational expression:
ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) weight (W) with the relational expression of fish oil or polyenoid fish oil addition is in per 100 gram finished product ready-mixed oils
W＝Wc×Xc
DHA and EPA weight ratio relational expression are in ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA and EPA weight ratio (R) and fish oil or the polyenoid fish oil
R＝X
DHA/X
EPA＝X
DHAc/X
EPAc
The relational expression that ω-3 long-chain polyunsaturated fatty acid in fish oil or the polyenoid fish oil (ω-3 LCPUFA) total amount, DHA, EPA weight account for its percentage by weight is
Xc＝X
DHAc+X
EPAc
In the above-mentioned relation formula:
W is ω-3 long-chain polyunsaturated fatty acid (ω-3 a LCPUFA) weight in per 100 gram finished product ready-mixed oils, and its weight range is 0.1～5.0g;
Wc be add in per 100 gram finished product ready-mixed oils fish oil or polyenoid fish oil weight; Xc accounts for the percentage of its weight for ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) total amount in the fish oil that adds or the polyenoid fish oil;
X
DHA, X
EPBe respectively DHA in the finished product ready-mixed oil, EPA weight accounts for its percentage by weight; X
DHAa, X
EPAaBe respectively DHA in the seal oil, EPA weight accounts for its percentage by weight.
(4) according to containing saturated fatty acid (SFA) 12～18g in the 100 gram finished product ready-mixed oils, monounsaturated fatty acids (MUFA) 39～46g, omega 6 polyunsaturated fatty acid (ω-6 PUFA) 31～38g, the requirement of omega-3 polyunsaturated fatty acids (ω-3 PUFA) 5～9g, fish oil or polyenoid fish oil according to required interpolation, saturated aliphatic acid (SFA) in the various raw material edible oils, monounsaturated fatty acids (MUFA), omega 6 polyunsaturated fatty acid (ω-6 PUFA), omega-3 polyunsaturated fatty acids (ω-3 LCPUFA) percentage composition is calculated the portion that all kinds of raw material edible oils should add.
(5) get the fish oil that calculates portion or the antioxidant of polyenoid fish oil, raw material edible oil and ormal weight, add in the material-compound tank, holding temperature is at 20～40 ℃, is stirred at a slow speed to mix, and filters, and promptly gets the ready-mixed oil finished product.
Beneficial effect of the present invention is:
The present invention replenishes ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA, EPA by vegetable fat, avoids other health products to forget and takes phenomenon, and reinforcing method is science more.The purpose that the present invention selects for use fish oil to realize replenishing ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) as additive has the following advantages:
The contained long-chain omega-3 polyunsaturated fatty acids of fish oil has comprised DHA, EPA, and its effect is respectively:
1, EPA: be commonly called as " blood vessel street cleaner ", can make certain prostaglandin, this prostaglandin can make angiomalacia and suppress blood platelet and condense in blood vessel, has the vascular sclerosis of preventing, cardiovascular and cerebrovascular embolism, reduces effects such as hypertension, high fat of blood and cholesterol.Be applicable to coronary sclerosis and thrombus, headstroke, cerebral hemorrhage, cerebrovascular disorder, high cholesterol, high fat of blood, hypertension, hand and foot numbness, various cardiovascular and cerebrovascular diseases such as palpitaition.
2, DHA: be commonly called as " brain gold ", content in optic cell and retinal tissue is up to 40～47%, be aliphatic acid important in brain, nerve, the cellula visualis, have the memory of enhancing and the power to think, improve intelligence, regulate and improve eyesight, reduce the incidence of women's neurasthenia in postpartum and depression, prevention and treatment senile dementia, prevention dry skin and aging, acceleration skeleton increases, preventing effects such as osteoporosis, is that brain tissue and optic nerve are grown and function is brought into play necessary nutriment.
The present invention has compiled the fatty acid proportion of different vegetable fat, see Table 1, moving according to difference, various fatty acid proportions in the vegetable fat, the absorption ratio of various aliphatic acid in China resident's that " DRIs " book of writing with reference to Chinese Soclety of Nutrition is recommended the diet nutritional intake, as shown in table 2, saturated fatty acid (SFA) to different crowd, monounsaturated fatty acids (MUFA), ω-6 is that polyunsaturated fatty acid (ω-6 PUFA) and ω-3 are that polyunsaturated fatty acid (ω-3 PUFA) requirement is calculated, draw Chinese residents meals grease intake, as shown in table 3.Concrete computational process is: become the human fatty acid intake to account for 20～30% of gross energy, saturated fatty acid (SFA): monounsaturated fatty acids (MUFA): polyunsaturated fatty acid (PUFA)=1: 1: 1 ratio, ω in the polyunsaturated fatty acid-6 are that polyunsaturated fatty acid (ω-6 PUFA) and ω-3 are that polyunsaturated fatty acid (ω-3 PUFA) ratio is 4～6: 1; Eating habit according to China resident, animal food can be brought fractional saturation aliphatic acid into, should deduct animal food in the finished product ready-mixed oil and can bring fractional saturation aliphatic acid into, so its saturated fatty acid (SFA): monounsaturated fatty acids (MUFA): the appropriate ratio of polyunsaturated fatty acid (PUFA) should be 0.35: 1: 1.One day fatty intake=(0.30 * RNI)/36700 of resident, 0.3 should account for the ratio of food intake gross energy for fat, RNI is the energy intake of the Chinese residents meals recommended of Chinese Soclety of Nutrition's " DRIs " of writing, 36700 is the energy that every gram fat produces in the food (J of unit, its value is more lower slightly than the energy 39700J that every gram fat in the body produces).As adult man of 18～49 years old age, be engaged in middle physical exertion, one day fatty intake=0.3 * 11.30 * 1000000 ÷ 36700=92.4g then, calculate its saturated fatty acid, monounsaturated fatty acids and polyunsaturated fatty acid intake thus and be 30.8g (calculating) by 1: 1: 1, ω in the polyunsaturated fatty acid-6 is that intake is 24.64～26.4g, and ω-3 is that intake is 6.2～4.4g (calculating by 4～26: 1).Because of the basic balance of aliphatic acid that provides in the loss aliphatic acid in the cooking process and other food, so every day, the vegetable fat demand still was 92.4g.As known from Table 3, the crowd of all ages and classes, sex, labour intensity fat requirement difference, fatty requirement is up to wet nurse, and every day, the fat requirement was 109.4g, and fatty requirement is minimum be child (young girl) over 1 years old, and every day, fatty requirement was 36.0g.
The present invention has also studied the health care and the medicine fish oil series products usage and dosage of data of literatures such as domestic and international nutrition, pharmacology and authoritative department recommended intake and China Ministry of Public Health and State Food and Drug Administration's approval, as the normative reference of adding content proportioning between ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) dosage and DHA, DPA, the EPA in the edible finished product ready-mixed oil of different crowd.
1, the U.S. is healthy advises taking everyone every day 1～3g ω-3 long-chain unsaturated fatty acid (ω-3 LCPUFA) jointly with nutrition service department and life science NI; 2,25～49 years old people of Canadian government department recommendation absorbs 1.5g omega-long chain 3 unrighted acids (ω-3 LCPUFA) every day; 3, the WHO of the World Health Organization advises that minimum DHA daily intake is 220mg, and the baby should be according to body weight, and each kilogram needs to replenish DHA40mg; 4, FAO of FAO (Food and Agriculture Organization of the United Nation) and the WHO of the World Health Organization, the ratio of advocating DHA/EPA in the infant food is greater than 10; 5, China Ministry of Public Health " food additives use sanitary standard (amendments in 2004) " (actual addition is 0.2～0.6g/kg) to the use amount of regulation DHA nutrition fortifier in babies ' formula milk powder in the baby milk powder as per kilogram 0.4～1.8g; 6, the Jin Aoli board fish oil soft capsule of the enhancing immunity that the crowd takes beyond the suitable infant [the strong word 620070025 of state's food], every day, taking dose was 33% fish oil (every 100g contains: DHA 20.0g, EPA 13.0g) 4000mg, be that the DHA+EPA total amount is 1320mg, the weight ratio of DHA and EPA is 1.54: 1, and wherein DHA content is 800mg; 7, be fit to children's fish oil soft capsule of children taking, every day, taking dose was 30% fish oil, 500～1000mg, and promptly the DHA+EPA total amount is 150～300mg, and the weight ratio of DHA and EPA is 2: 1～5: 1, and wherein DHA content is not less than 100mg; 8, general adult takes fish oil based article such as deep-sea fish oil soft capsules, and every day, taking dose was 30% fish oil, 1000～2000mg, and promptly the DHA+EPA total amount is 300～600mg, and the weight ratio of DHA and EPA is 0.67: 1; 9, medicine ethyl polyenoate capsule and pill [national drug standards WS1-XG-023-2000] regulation taking dose every day that is applicable to the hyperlipemia patient is DHA+EPA total amount 7500～1500mg, and the ratio of DHA and EPA must not be greater than 0.4; 10, improve the luxuriant growth Bi health board algal oil capsule that memory person uses [the strong word G20040547 of state's food], every day taking dose be 20% algal oil (every 100g contains: 675mg DHA 20g), promptly DHA content is 135mg, does not contain EPA; 11, little algae oil DHA soft capsule of Changsha Jia Ge Bioisystech Co., Ltd production, pregnant and ylying-in woman is taken 60% little algae oil (every 100g contains: DHA 42.0g, DPA 18.0g, EPA 0.8g), 500～1000mg every day, be that DHA content is 210～420mg, DPA+EPA content is 94～188mg, and EPA content is 4～8mg; Every day taken 360～720mg by infant's type, and promptly DHA content is 151～302mg, and DPA+EPA content is 68～135mg, and EPA content is 3～6mg; Every day taken 250～500mg by the youngsters and children type, and promptly DHA content is 105～210mg, and DPA+EPA content is 47～94mg, and EPA content is 2～4mg.
The present invention analyzes above-mentioned health care and medicine fish oil series products usage and dosage, to save cost under the prerequisite that fully satisfies the different crowd psychological need as far as possible is principle, think: contain in the nutrient blend oil of fish oil or polyenoid fish oil every 100g and contain ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) total amount and should be 0.1～5g, simultaneously product is pressed all ages and classes and type crowd to DHA, the demand difference of EPA is divided into following several types: 1, children and youth auxotype: children, the teenager is in cranial nerve and optic nerve growth and development stage, and is higher to the DHA demand percentage; For promoting and improve the immunity of human body, the healthy development of maintenance cycle system needs a certain amount of DPA; EPA significantly suppresses the arachidonic biosynthesis of endogenous in low age crowd (particularly baby) body, hinders its intelligence and skeleton development, should control its content, thus children, teenager DHA: EPA should be 4: 1～10: 1; 2, pregnant nursling children auxotype: fetus, baby, child, pregnant woman, wet nurse are higher to the demand percentage of DHA, and DHA: EPA should be 10: 1～and 25: 1; The cardiovascular health-care function type: cardiovascular and cerebrovascular disease patient and the elderly take into account the prevention senile dementia, DHA to reduce blood fat, blood sugar, blood pressure and to eliminate thrombus: EPA should be 0.25: 1～and 0.7: 1; Household economy is practical: for common healthy population, based on the prevention cardiovascular and cerebrovascular disease and strengthen memory and improve eyesight, DHA and EPA content proportioning are answered relative equilibrium, DHA: EPA should be 0.7: 1～and 2: 1.
The present invention has taken into full account the loss in the cooking process, measure content, soybean oil drug standard [" Chinese pharmacopoeia 2005 version two ones] the equal size assay method of omega-3 polyunsaturated fatty acids (ω-3 PUFA) in the fish oil capsule and pill with reference to ethyl polyenoate quality standard [national drug standards WS1-XG-023-2000], " Pharmaceutical Analysis magazine " the 5th phase in 2004 " capillary gas chromatography ", investigated DHA, EPA in the heating stable case that meets under the cooking temp condition, experiment content is:
1, instrument and reagent
Tianjin, island 17A gas chromatograph, fid detector (flame ionization ditector), gas-chromatography work station.
25% fish oil, 45% polyenoid fish oil are available from marine biotechnology Co., Ltd of Zhejiang divine boat; Methyl eicosapentaenoic acid (EPA, 9.99mg.mL
-1), 20 carbon, two acid methyl esters (DHA, 9.99mg.mL
-1) reference substance solution is all available from Supelco company, it is pure that boron trifluoride methanol solution [concentration is 50% (w/v)], n-hexane, methyl alcohol, NaOH are analysis.
2, chromatographic condition
Capillary column: Supelco-Wax (30m * 0.53mm, 0.25 μ m); Column temperature: 220 ℃, injector temperature is 250 ℃, 260 ℃ of detector temperatures.Carrier gas is nitrogen (99.99%), and post is pressed and is 42kPa, flow velocity: 2 ml.min
-1, linear velocity: 47cm.s
-1, split ratio: 1: 1.
3, precision test
Getting " 4 " concentration is 500ug.mL
-1EPA, DHA solution, METHOD FOR CONTINUOUS DETERMINATION 5 times, its peak area RSD value is respectively 0.93%, 1.15% (n=5) as a result.
4, linear test
Precision is measured EPA methyl esters (9.99mg.mL respectively
-1), DHA methyl esters (9.99mg.mL
-1) reference substance, DPA methyl esters (9.99mg.mL
-1) reference substance 1ml puts respectively in the 10ml measuring bottle, with the n-hexane dilution and be settled to scale, shakes up product storing solution in contrast.Precision is measured reference substance storing solution stepwise dilution, makes the solution of a series of concentration.Getting the luL inject gas chromatograph respectively, measure each peak area, is ordinate (Y) with the peak area of reference substance, and concentration is abscissa (X), carries out linear regression.The regression equation of EPA, DPA, DHA (n=7) is respectively as a result:
Y
EPA＝1343.3
XEPA-1784.8 r＝0.9999
Y
DHA＝1040.2
XDHA-1216.2 r＝0.9999
All at 5.0-1000ug.mL
-1Be good linear relationship in the concentration range.
5, recovery test
Get the about 100mg of embodiment 1 base oil (not containing alloyd oil), the accurate title, decide, and puts in the 25ml tool plug reaction bulb, and accurate each 1ml of reference substance stock solution that adds makes 3 parts altogether, adds 0.5mol.mL
-1Sodium hydrate methanol solution 2mL, close plug, put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 3mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision adds n-hexane 4ml, saturated nacl aqueous solution 4mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, after using 5 times of above-mentioned solution of dilution of n-hexane before the sample introduction, precision is measured the luL inject gas chromatograph, calculates by external standard method, calculates average recovery rate with the amount of recording and addition.EPA, DHA average recovery rate are respectively 9 8.5% as a result, and 99.1%, n=3.
6, repeatability
Get same No. 1 sample a, by " 8.2.1 " method operation down, make 5 parts of need testing solutions, measure by above-mentioned chromatographic condition, the RSD (n=6) that records EPA, DHA content is respectively 1.48%, 1.42% (n=5).
7, stability
Get same No. 1 sample a, make need testing solution by method operation under " 8.2.1 " item, respectively 0,2,4,6, the 8h sample introduction is measured, and the sample peak area remains unchanged substantially, and the RSD value of EPA, DHA peak area is respectively 1.27%, 1.31%.
8, sample determination
8.1 sample preparation
The fish oil class
No. 1 sample: 25% fish oil (triglyceride type)
Preparation method: get 25% fish oil that does not heat, be sample a; Get 25% fish oil 50g, by the straight fiery heat temperature raising to 200 of culinary art condition ℃ (heating-up time is 2～3 minutes) sampling rapidly, cooling immediately gets sample b; In 200～250 ℃ of temperature ranges, keep temperature to take a sample with method in the time of 2 minutes, get sample c; Keep temperature to take a sample with method in the time of 4 minutes, get sample d; Temperature retention time was taken a sample with method in the time of 6 minutes, got sample e.No. 2 samples: get 25% fish oil 10g, be mixed with 100g with embodiment 1 base oil.
Preparation method: prepare sample a, b, c, d, e with " No. 1 sample " method.No. 3 samples: get 25% fish oil 1.5g, be mixed with 100g with embodiment 1 base oil.
Preparation method: prepare sample a, b, c, d, e with " No. 1 sample " method.Polyenoid fish oil class (ethyl ester type)
No. 4 samples: 45% polyenoid fish oil
Preparation method: with " No. 1 sample " preparation method's product sample a, b, c, d, e.No. 5 samples: 45% fish oil 11g is mixed with 100g with embodiment 1 base oil.
Preparation method: prepare sample a, b, c, d, e with " No. 1 sample " method.8.2.1 1, No. 4 samples
Get about 100mg, the accurate title, decide, and puts in the 25ml tool plug reaction bulb, adds 0.5mol.mL
-1Sodium hydrate methanol solution 2mL, close plug is put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 3mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision is with normal heptane 4ml, saturated nacl aqueous solution 4mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, place in 4 ℃ of refrigerators.After using 5 times of above-mentioned solution of dilution of n-hexane before the sample introduction, as need testing solution.8.2.2 2, No. 5 samples
Get about 100mg, the accurate title, decide, and puts in the 25ml tool plug reaction bulb, adds 0.5mol.mL
-1Sodium hydrate methanol solution 4mL, close plug is put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 6mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision is with normal heptane 4ml, saturated nacl aqueous solution 4mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, place in 4 ℃ of refrigerators.Divide before the sample introduction and get supernatant, as need testing solution.
8.2.3 No. 3 samples
Get the about 1200mg of sample No. 3, the accurate title, decide, and puts in the 250ml tool plug reaction bulb, adds 0.5mol.mL
-1Sodium hydrate methanol solution 24mL, close plug is put extremely little oil droplet complete obiteration of jolting in 50 ℃ of water-baths, add boron trifluoride methanol solution 36mL, mixing is put in 50 ℃ of water-baths and is placed 5min, take out, cooling, precision is with normal heptane 8ml, saturated nacl aqueous solution 12mL, jolting, static, get supernatant in another tool plug test tube, add a small amount of anhydrous sodium sulfate, place in 4 ℃ of refrigerators.Divide before the sample introduction and get supernatant, as need testing solution.
8.3 sample determination
Precision is measured 500ug.mL
-1EPA, DPA, DHA reference substance solution and need testing solution 1uL be inject gas chromatograph respectively, and the record chromatogram calculates test sample EPA, DHA, DPA content by external standard method.The sample size measurement result sees Table 4.
9, blank test
Get embodiment 1 base oil and prepare blank sample with " 8.2.1 " sample extraction method, press the sample size condition determination and measure, the result chromatographic peak do not occur in the corresponding retention time of EPA, DHA, and base oil is noiseless to assay.
Assay is the result show, fish oil or polyenoid fish oil crude oil and finished product tempered oil thereof heat (2～3 minutes heating-up times) when promptly being warming up to 200 ℃ under the culinary art condition, keep temperature in the time of 2,4,6 minutes in 200～250 ℃ again, the storage rate of EPA, DHA is about 98%, 95%, 92%, 90%, and heating is little to its content influence under the culinary art condition; By advocating the cooking methods of science, promptly adding after the ready-mixed oil a little, heat (temperature is no more than 200 ℃) promptly begins dish down, or when taking the dish out of the pot, add ready-mixed oil again, and reduce heating temperature and reduce heated time, can more effectively guarantee (the absorption of ω-3LCPUFA) of ω-3 long-chain polyunsaturated fatty acid.This finished product ready-mixed oil is better as the edible oil effect in cold dish, the instant food.
The antioxidant fat-soluble tea polyphenol that adds in the finished product ready-mixed oil of the present invention; can protect polyunsaturated fat to avoid oxidation Decomposition such as oxygen radical; keep grease stable, have the lipid metabolism of adjusting again, reduce blood fat, suppress atherosclerotic generation and the incidence of various cardiovascular and cerebrovascular diseases such as development, reduction coronary heart disease and the effect of the death rate.
The antioxidant vitamin E that adds in the finished product ready-mixed oil of the present invention; can be to the peroxidation of Green Tea Extract; the protection polyunsaturated fat is avoided the radical damage oxidation Decomposition; keep grease stable, can protect cell membrane, nerve and muscle to avoid oxygen free radical injury again, keep the normal development and the function of nerve, muscle; the protection red blood cell avoids haemolysis; can also be anti-ageing, protection skin, strengthen ovarian function, prevent habitual abortion.
Cardiovascular and cerebrovascular type nutrient blend oil provided by the present invention has the following advantages:
1, at cardio-cerebral vascular disease patient and middle-aged and old physilogical characteristics, got rid of the rapeseed oil that contains erucic acid, prevented that erucic acid from causing " myocardium fat deposition " phenomenon of cardiovascular functional disorder patient.
2, DHA, EPA content proportioning science, have following health care: A, reduce cholesterol, angiocardiopathy preventing, the prevention thrombosis reduces artery sclerosis and hypertension, reduction blood viscosity, stimulates circulation, eliminate fatigue, alleviate gout and rheumatic arthritis.The incidence of disease of B, minimizing coronary artery heart disease.The prevention of suitable high cholesterol, artery sclerosis, high fat of blood, hypertension, heart disease, fatty liver, obesity etc.C, improvement memory, the prevention senile dementia; D, protection retina improve eyesight.
3, selected for use have expansion and softening blood vessel, prevent thrombosis, increase blood circulation, pre-anti-aging and regulate the safflower seed oil of effects such as endocrine, safflower seed oil is known as the linoleic acid king by nutrition circle, its linoleic acid content can be up to 80%.
Pregnant nursling children nutrient blend oil provided by the present invention has the following advantages:
1, DHA, EPA content proportioning science can promote the growth of fetus, baby, child's brain, retina and physical efficiency thereof.
2, the walnut oil of Tian Jiaing has been rich in leukotrienes, vitamin A, vitamin E, folic acid, 18 seed amino acids, carotene, thiamine, flavonol, trace elements such as zinc, manganese, chromium, have brain-tonifying and kidney-nourishing, moisten the lung and relieve the cough, fill blood, effect such as blacking hair and nourishing face, anti-ageing, reducing blood lipid, prevention diabetes, can increase pregnant woman's skin elasticity, alleviate and eliminate cyasma, promote fetal brain tissue development and intelligence to increase.
3, the prescription grease is non-transgenic, has ensured fetus, baby, child's food security.
Children and youth type nutrient blend oil provided by the present invention has the following advantages:
1, DHA, EPA content proportioning science can promote the growth of brain, retina and physical efficiency thereof, strengthen memory, improve learning ability, improve eyesight.
2, the walnut oil of Tian Jiaing can in time replenish brain nutrition, alleviates and eliminates brain fag, improves memory and thinking, is of value to children, adolescent growth is grown.
3, the prescription grease is non-transgenic, has ensured children, teen-age edible safety.
Economical and practical type nutrient blend oil provided by the present invention has the following advantages:
1, DHA, EPA content proportioning science, can reduce cholesterol, improve hypertension, adjust blood fat, prevention miocardial infarction, diseases such as headstroke, fatty liver, artery sclerosis, can strengthen memory again, improve learning ability, prevent alzheimer's disease and improve eyesight, satisfy healthy population physiology and nutritional need.
2, consider to understand ordinarily resident's physiology and nutritional need and purchasing power, the economic formula material benefit meets nutrition, health care requirement, and it is edible to be fit to common healthy population.
The specific embodiment
Embodiment 1～76 each raw material edible oil, fish oil or polyenoid fish oil proportioning composition see Table 5,6.
Its production stage is:
(1) by the selected raw material edible oil of each embodiment (seeing Table 5);
(2) by selected fish oil of each embodiment (seeing Table 6) or polyenoid fish oil;
(3) calculate the addition of fish oil or polyenoid fish oil according to computing formula;
(4) calculate the portion that all kinds of raw material edible oils should add;
(5) get the antioxidant of the raw material edible oil, fish oil or polyenoid fish oil and the ormal weight that calculate portion, evenly mix.
In each embodiment grease prescription, various fatty acid wts, ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA+EPA total amount, DHA and EPA weight ratio see table 6 for details in the 100g finished product ready-mixed oil.
Embodiment 1～24 is a cardiovascular health-care function type ready-mixed oil, and embodiment 25～48 is pregnant nursling children auxotype ready-mixed oil, and embodiment 49～62 is a children and youth auxotype ready-mixed oil, and embodiment 63～76 is the practical ready-mixed oil of household economy.
The present invention is including but not limited to above-mentioned embodiment; as long as adopted the method for in grease, adding fish oil or polyenoid fish oil etc. and obtaining to contain the nutrition balanced mixed oil of ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA), promptly belonged to protection scope of the present invention.
Aliphatic acid is formed in table 1, the vegetable fat commonly used
| The name of an article | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega 6 polyunsaturated fatty acid | Other |
| Linseed oil | 12.4 | 20.7 | 16.2 | 50.7 | |
| Crust sesame oil | 10.0 | 12.0 | 53.0 | 25.0 | |
| 25～35% fish oil, polyenoid fish oil | 25.0 | 37.0 | 3.0 | 35.0 | |
| 45～55% fish oil, polyenoid fish oil | 17.3 | 25.6 | 2.1 | 55.0 | |
| 65～75% polyenoid fish oil | 9.6 | 14.2 | 1.2 | 75.0 | |
| Olive oil | 10.0 | 83.0 | 7.0 | 1.0 | |
| Soybean oil | 16.5 | 24.0 | 52.0 | 7.5 | 3 |
| Corn oil | 14.8 | 28.3 | 55.8 | 1.1 | 2 |
| Peanut oil | 19.1 | 42.9 | 37.3 | 0.7 | |
| Rapeseed oil | 7.2 | (63.5 wherein erucic acid 0-42) | 19.6 | 9.7 | |
| Cottonseed oil | 28.0 | 25.0 | 44.0 | 0 | |
| Sunflower oil | 13.6 | 23.1 | 61.6 | 1.7 | |
| Tea-seed oil | 10.0 | 79.0 | 10.0 | 1.0 | |
| Safflower seed oil | 9.0 | 13.2 | 76.6 | 1.2 | |
| Wheat-germ oil | 5.0 | 15.0 | 70.0 | 10.0 | |
| Walnut oil | 10.0 | 23.0 | 58.0 | 9.0 | |
| Sesame oil | 15.0 | 38.0 | 46.0 | 0.3 | 1 |
| Rice bran oil | 21.0 | 43.0 | 33.0 | 3.0 | |
| Palm oil | 44.0 | 44.0 | 12.0 | ||
| Purple Perilla Seed Oil | 8.7 | 12.4 | 15.0 | 62.5 | 1.4 |
| 15～22.5% seal oils | 28.6 | 45.0 | 1.4 | 22.5 | 2.5 |
| 30% seal oil | 17.0 | 30.0 | 16.5 | 32.0 | 4.5 |
| 55% seal oil | 15.0 | 25.0 | 55.0 | 5.0 | |
| 40% algal oil | 35.7 | 22.1 | 1.3 | 40.0 | |
| 60% algal oil | 27.0 | 12.2 | 60.8 |
Table 2, Chinese residents diet energy recommended intake (RNIs)
| Age/year | Type | RNI/(MJ/d) | Age/year | Type | RNI/(MJ/d) | ||
| The man | The woman | The man | The woman | ||||
| 0～ | 0.40MJ/(kg.d)① | 18～ | Light physical labor | 10.04 | 8.80 | ||
| 0.5～ | 0.40MJ/(kg.d)① | Middle physical exertion | 11.30 | 9.62 | |||
| 1～ | 4.60 | 4.40 | Ass work is moving | 13.38 | 11.30 | ||
| 2～ | 5.02 | 4.81 | Pregnant woman's (4～June) | +0.84 | |||
| 3～ | 5.64 | 5.43 | Pregnant woman's (7～September) | +0.84 | |||
| 4～ | 6.06 | 5.85 | Wet nurse | +2.09 | |||
| 5～ | 6.70 | 6.27 | 50～ | Light physical labor | 9.62 | 7.94 | |
| 6～ | 7.10 | 6.70 | Middle manual labor | 10.87 | 8.36 | ||
| 7～ | 7.53 | 7.10 | Heavy physical labour | 13.00 | 9.20 | ||
| 8～ | 7.94 | 7.53 | 60～ | Light physical labor | 7.94 | 7.53 | |
| 9～ | 8.36 | 7.94 | Middle manual labor | 9.20 | 8.36 | ||
| 10～ | 8.80 | 8.36 | 70～ | Light physical labor | 7.94 | 7.10 | |
| 11～ | 10.04 | 9.20 | Middle manual labor | 8.80 | 7.94 | ||
| 14～ | 12.12 | 10.04 | 80～ | 7.94 | 7.10 | ||
1. be AI, NBF should increase by 20% (DRIs, 2000)
Table 3, Chinese residents dietary fat recommended intake
| Age/year | Type | Total fatty intake (g/d) | Age/year | Type | Total fatty intake (g/d) | ||
| The man | The woman | The man | The woman | ||||
| 0～ | 3.27g/(kg.d)① | 18～ | Light physical labor | 82.04 | 71.93 | ||
| 0.5～ | 3.27g/(kg.d)① | Middle physical exertion | 92.37 | 78.64 | |||
| 1～ | 37.60 | 35.97 | Ass work is moving | 109.37 | 92.37 | ||
| 2～ | 41.04 | 39.32 | Pregnant woman's (4～June) | 99.23 | |||
| 3～ | 46.10 | 44.39 | Pregnant woman's (7～September) | 99.23 | |||
| 4～ | 49.54 | 47.82 | Wet nurse | 109.45 | |||
| 5～ | 54.77 | 51.25 | 50～ | Light physical labor | 78.64 | 64.90 | |
| 6～ | 58.04 | 54.77 | Middle manual labor | 88.85 | 68.34 | ||
| 7～ | 61.55 | 58.04 | Heavy physical labour | 106.26 | 75.20 | ||
| 8～ | 64.90 | 61.55 | 60～ | Light physical labor | 64.90 | 61.55 | |
| 9～ | 68.34 | 64.90 | Middle manual labor | 75.20 | 68.34 | ||
| 10～ | 71.93 | 68.34 | 70～ | Light physical labor | 64.90 | 58.04 | |
| 11～ | 82.07 | 75.20 | Middle manual labor | 71.93 | 64.90 | ||
| 14～ | 99.1 5 | 82.07 | 80～ | 64.90 | 58.04 | ||
1. be AI, NBF should increase by 20%, calculates according to " DRIs " (2000) that Chinese Soclety of Nutrition is recommended.
2. saturated fatty acid (SFA), monounsaturated fatty acids (MUFA) and polyunsaturated fatty acid (PUFA) ginseng recommended intake are 0.333 * total fatty intake (calculating by 1: 1: 1); ω in the polyunsaturated fatty acid-6 is that the aliphatic acid intake is 0.266 * total fatty intake～0.283g * total fatty intake, and ω-3 is that the aliphatic acid intake is 0.067 * total fatty intake～0.048g * total fatty intake (calculating by 4～6: 1).
Table 4, sample DHA, EPA assay result (g/100g)
| Sample | No. 1 | No. 2 | No. 3 | No. 4 | No. 5 | ||||||||||
| EPA | DHA | Add up to | EPA | DHA | Add up to | EPA | DHA | Add up to | EPA | DHA | Add up to | EPA | DHA | Add up to | |
| A (not heating) | |||||||||||||||
| Content | 14.61 | 11.70 | 26.31 | 1.40 | 1.07 | 2.47 | 0.23 | 0.18 | 0.41 | 25.79 | 19.]4 | 44.93 | 2.86 | 2.13 | 4.99 |
| B (being heated to 200 ℃) | |||||||||||||||
| Content | 14.46 | 11.61 | 26.07 | 1.40 | 1.05 | 2.45 | 0.23 | 0.17 | 0.40 | 25.53 | 18.95 | 44.48 | 2.83 | 2.10 | 4.93 |
| Storage rate (%) | 99.0 | 99.2 | 99.1 | 100.0 | 98.1 | 99.2 | 100.0 | 94.4 | 97.6 | 99.0 | 99.0 | 99.0 | 99.0 | 98.6 | 98.8 |
| C (200 ℃～250 ℃ kept 2 minutes) | |||||||||||||||
| Content | 13.88 | 10.95 | 24.83 | 1.34 | 1.03 | 2.37 | 0.22 | 0.17 | 0.39 | 24.5l | 18.20 | 42.7l | 2.72 | 2.03 | 4.75 |
| Storage rate (%) | 95.0 | 93.6 | 94.4 | 95.7 | 96.3 | 96.0 | 95.7 | 94.4 | 95.1 | 95.0 | 95.1 | 95.1 | 95.1 | 95.3 | 95.1 |
| D (200 ℃～250 ℃ kept 4 minutes) | |||||||||||||||
| Content | 13.45 | 10.76 | 24.21 | 1.29 | 0.97 | 2.26 | 0.21 | 0.17 | 0.38 | 23.98 | 17.80 | 41.78 | 2.66 | 1.97 | 4.63 |
| Storage rate (%) | 92.1 | 92.0 | 92.0 | 92.1 | 90.7 | 91.5 | 91.3 | 94.4 | 92.7 | 93.0 | 93.0 | 93.0 | 93.0 | 92.5 | 92.8 |
| E (200 ℃～250 ℃ kept 6 minutes) | |||||||||||||||
| Content | 13.30 | 10.51 | 23.8l | 1.28 | 0.94 | 2.22 | 0.2l | 0.16 | 0.37 | 23.47 | 17.23 | 40.70 | 2.62 | 1.94 | 4.56 |
| Storage rate (%) | 91.0 | 90.0 | 90.5 | 90.6 | 88.7 | 89.9 | 91.3 | 88.9 | 90.2 | 91.0 | 90.0 | 90.6 | 91.6 | 91.1 | 91.4 |
Table 5, each feedstock oil addition (g/100g) of embodiment
| Embodiment | The prescription grease | |||||||||||||
| Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
| 1 | 30 | 10 | 18 | 5 | 6 | 23 | 4 | 0.02 | ||||||
| 2 | 30.7 | 10 | 18 | 5 | 6 | 23 | 4 | 0.01 | 0.02 | |||||
| 3 | 30.7 | 10 | 18 | 5 | 6 | 23 | 4 | 0.03 | ||||||
| 4 | 32 | 10 | 18 | 5 | 6 | 23 | 4 | 0.01 | ||||||
| 5 | 32.6 | 10 | 18 | 5 | 6 | 23 | 4 | 0.01 | ||||||
| 6 | 38 | 10 | 20 | 4 | 6 | 18 | 0.01 | |||||||
| 7 | 38.7 | 10 | 20 | 4 | 6 | 18 | 0.008 | 0.02 | ||||||
| 8 | 40 | 10 | 20 | 4 | 6 | 18 | 0.01 | 0.02 | ||||||
| 9 | 42 | 10 | 20 | 6 | 10 | 8 | 0.008 | 0.02 | ||||||
| 10 | 42.7 | 10 | 20 | 6 | 10 | 8 | 0.01 | |||||||
| 11 | 44 | 10 | 20 | 6 | 10 | 8 | 0.01 | |||||||
| 12 | 42 | 10 | 20 | 10 | 8 | 0.008 | 0.01 | |||||||
| 13 | 42 | 10 | 20 | 10 | 8 | 0.008 | 0.02 | |||||||
| 14 | 42 | 12.9 | 20 | 10 | 8 | 0.008 | 0.02 | |||||||
| 15 | 20 | 15 | 3 | 28 | 6 | 24 | 0.01 | |||||||
| 16 | 20.7 | 15 | 3 | 28 | 6 | 24 | 0.008 | 0.02 | ||||||
| 17 | 22 | 15 | 3 | 28 | 6 | 24 | 0.008 | 0.02 | ||||||
| 18 | 21 | 15 | 3 | 28 | 6 | 24 | 0.008 | 0.02 | ||||||
| 19 | 20 | 15 | 3 | 28 | 6 | 22 | 2 | 0.006 | 0.04 | |||||
| 20 | 20.7 | 15 | 3 | 28 | 6 | 22 | 2 | 0.006 | 0.04 | |||||
Table 5, each feedstock oil of embodiment, antioxidant addition (g/100g)-continuous 1
| Embodiment | The prescription grease | |||||||||||||
| Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
| 21 | 21 | 15 | 3 | 28 | 6 | 22 | 2 | 0.006 | 0.04 | |||||
| 22 | 24 | 15 | 5 | 10.6 | 17 | 23 | 5 | 0.01 | ||||||
| 23 | 24 | 15 | 5 | 10.7 | 17 | 23 | 5 | 0.01 | ||||||
| 24 | 25 | 15 | 5 | 7 | 17 | 23 | 5 | 0.008 | 0.02 | |||||
| 25 | 25 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.05 | |||||
| 26 | 25.7 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.08 | |||||
| 27 | 25.7 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.05 | |||||
| 28 | 27 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.08 | |||||
| 29 | 27.6 | 15 | 4 | 9 | 15 | 5 | 23 | 0.003 | 0.05 | |||||
| 30 | 25 | 15 | 5 | 15 | 8 | 5 | 23 | 0.2 | ||||||
| 31 | 25.7 | 15 | 5 | 15 | 8 | 5 | 23 | 0.12 | ||||||
| 32 | 26 | 15 | 5 | 15 | 8 | 5 | 23 | 0.12 | ||||||
| 33 | 26.9 | 15 | 5 | 15 | 8 | 5 | 23 | 0.12 | ||||||
| 34 | 28 | 15 | 5 | 7 | 14 | 5 | 20 | 0.002 | 0.06 | |||||
| 35 | 29 | 15 | 5 | 7 | 14 | 5 | 20 | 0.003 | 0.05 | |||||
| 36 | 39 | 15 | 5 | 7 | 14 | 5 | 20 | 0.003 | 0.05 | |||||
| 37 | 32.6 | 15 | 5 | 7 | 14 | 5 | 20 | 0.003 | 0.05 | |||||
| 38 | 30 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
| 39 | 30.7 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
| 40 | 30 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
Table 5, each feedstock oil of embodiment, antioxidant addition (g/100g)-continuous 2
| Embodiment | The prescription grease | |||||||||||||
| Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
| 41 | 32.6 | 15 | 5 | 15 | 6 | 5 | 20 | 0.003 | 0.05 | |||||
| 42 | 38 | 32 | 6 | 20 | 0.002 | 0.08 | ||||||||
| 43 | 38.7 | 32 | 6 | 20 | 0.003 | 0.05 | ||||||||
| 44 | 38 | 32 | 6 | 20 | 0.003 | 0.05 | ||||||||
| 45 | 40.6 | 32 | 6 | 20 | 0.003 | 0.05 | ||||||||
| 46 | 34 | 27 | 4 | 5 | 5 | 20 | 0.003 | 0.04 | ||||||
| 47 | 34 | 27 | 4 | 5 | 5 | 20 | 0.003 | 0.04 | ||||||
| 48 | 34 | 27 | 4 | 5 | 5 | 20 | 0.003 | 0.04 | ||||||
| 49 | 25 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
| 50 | 25.7 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
| 51 | 27 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
| 52 | 27.6 | 15 | 35 | 14 | 4 | 3 | 0.004 | 0.03 | ||||||
| 53 | 27 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
| 54 | 28 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
| 55 | 30 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
| 56 | 30.9 | 33 | 14.5 | 17 | 2.5 | 0.004 | 0.03 | |||||||
| 57 | 21 | 12 | 38 | 18 | 5 | 2 | 0.004 | 0.03 | ||||||
| 58 | 21.7 | 12 | 38 | 18 | 5 | 2 | 0.004 | 0.03 | ||||||
| 59 | 23 | 12 | 38 | 18 | 5 | 2 | 0.004 | 0.03 | ||||||
| 60 | 19 | 36 | 15 | 5 | 15 | 5 | 0.004 | 0.03 | ||||||
Table 5, each feedstock oil of embodiment, antioxidant addition. (g/100g)-continuous 3
| Embodiment | The prescription grease | |||||||||||||
| Peanut oil | Sunflower oil | Two low rapeseed oils | Soybean oil | Sesame oil | Linseed oil | Corn oil | Purple Perilla Seed Oil | Walnut oil | Tea-seed oil | Safflower seed oil | Olive oil | Fat-soluble tea polyphenol | Vitamin E | |
| 61 | 21 | 36 | 15 | 5 | 15 | 5 | 0.004 | 0.03 | ||||||
| 62 | 21.9 | 36 | 15 | 5 | 15 | 5 | 0.004 | 0.03 | ||||||
| 63 | 20 | 36 | 35 | 5 | 0.005 | 0.02 | ||||||||
| 64 | 20.7 | 36 | 35 | 5 | 0.008 | |||||||||
| 65 | 22 | 36 | 35 | 5 | 0.008 | |||||||||
| 66 | 22.6 | 36 | 35 | 5 | 0.005 | 0.01 | ||||||||
| 67 | 19 | 27 | 40 | 3 | 3 | 3 | 0.005 | 0.01 | ||||||
| 68 | 21 | 27 | 40 | 3 | 3 | 3 | 0.005 | 0.01 | ||||||
| 69 | 21.9 | 27 | 40 | 3 | 3 | 3 | 0.005 | 0.01 | ||||||
| 70 | 25 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
| 71 | 25.7 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
| 72 | 27 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
| 73 | 26.9 | 15 | 40 | 14 | 2 | 0.005 | 0.02 | |||||||
| 74 | 25.7 | 36 | 14 | 4 | 15 | 2 | 0.006 | 0.01 | ||||||
| 75 | 27 | 36 | 14 | 4 | 15 | 2 | 0.006 | 0.01 | ||||||
| 76 | 26.9 | 36 | 14 | 4 | 15 | 2 | 0.006 | 0.01 | ||||||
Table 6, embodiment admix oily fish oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)
| Embodiment | Alloyd oil (addition and percentage composition) | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
| Fish oil | Polyenoid fish oil (fatty acid triglycercide type) | Polyenoid fish oil (fatty-acid ethyl ester type) | Composition | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||
| Percent of total | DHA percentage | EPA percentage | DHA+EPA | DHA/EPA | ||||||||
| 1 | 4 | 15.2 | 42.9 | 35.5 | 6.4 | 1.0 | 0.67∶1 | |||||
| 2 | 3.3 | 30 | 12.4 | 17.6 | 15.2 | 42.9 | 35.7 | 6.1 | 1.0 | 0.70∶1 | ||
| 3 | 3.3 | 30 | 12.4 | 17.6 | 15.0 | 42.9 | 35.7 | 6.1 | 1.0 | 0.70∶1 | ||
| 4 | 2 | 50 | 20 | 30 | 14.9 | 42.8 | 36.1 | 7.1 | 1.0 | 0.67∶1 | ||
| 5 | 1.4 | 70 | 14 | 56 | 14.8 | 42.7 | 36.3 | 6.1 | 1.0 | 0.25∶1 | ||
| 6 | 4 | 25 | 10 | 15 | 16.1 | 42.0 | 35.5 | 6.5 | 1.0 | 0.67∶1 | ||
| 7 | 3.3 | 30 | 12 | 18 | 16.0 | 43.5 | 35.7 | 6.3 | 1.0 | 0.67∶1 | ||
| 8 | 2 | 50 | 20 | 30 | 15.8 | 41.8 | 36.1 | 6.3 | 1.0 | 0.67∶1 | ||
| 9 | 4 | 25 | 10 | 15 | 16.2 | 42.5 | 34.9 | 6.5 | 1.0 | 0.67∶1 | ||
| 10 | 3.3 | 30 | 12 | 18 | 16.2 | 42.5 | 35.1 | 6.3 | 1.0 | 0.67∶1 | ||
| 11 | 2 | 50 | 20 | 30 | 16.8 | 42.3 | 35.6 | 6.3 | 1.0 | 0.67∶1 | ||
| 12 | 10 | 50 | 20 | 30 | 16.2 | 42.3 | 33.7 | 7.6 | 5.0 | 0.67∶1 | ||
| 13 | 10 | 50 | 20 | 30 | 16.2 | 42.3 | 33.7 | 7.6 | 5.0 | 0.67∶1 | ||
| 14 | 7.1 | 70 | 28 | 42 | 15.6 | 41.4 | 35.4 | 7.5 | 5.0 | 0.67∶1 | ||
| 15 | 4 | 25 | 10 | 15 | 14.8 | 42.4 | 35.7 | 7.0 | 1.0 | 0.67∶1 | ||
| 16 | 3.3 | 30 | 12 | 18 | 14.8 | 42.5 | 35.9 | 6.7 | 1.0 | 0.67∶1 | ||
| 17 | 2 | 50 | 20 | 30 | 14.5 | 42.3 | 36.4 | 6.7 | 1.0 | 0.67∶1 | ||
| 18 | 3 | 50 | 20 | 30 | 14.5 | 42.3 | 36.4 | 7.2 | 1.5 | 0.67∶1 | ||
| 19 | 4 | 25 | 10 | 15 | 14.8 | 42.5 | 35.6 | 7.0 | 1.0 | 0.67∶1 | ||
| 20 | 3.3 | 30 | 12 | 18 | 14.8 | 42.5 | 35.9 | 6.7 | 1.0 | 0.67∶1 | ||
Table 6, embodiment admix oily fish oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)-continuous 1
| Embodiment | Alloyd oil (addition and percentage composition) | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
| Fish oil | Polyenoid fish oil (fatty acid triglycercide type) | Polyenoid fish oil (fatty-acid ethyl ester type) | Composition | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||
| Percent of total | DHA percentage | EPA percentage | DHA+EPA | DHA/EPA | ||||||||
| 21 | 3 | 50 | 20 | 30 | 14.5 | 42.2 | 35.9 | 7.2 | 1.5 | 0.67∶1 | ||
| 22 | 0.4 | 25 | 5 | 20 | 14.5 | 41.8 | 36.2 | 7.3 | 0.1 | 0.25∶1 | ||
| 23 | 0.33 | 30 | 12 | 18 | 14.5 | 41.8 | 36.8 | 7.3 | 0.1 | 0.67∶1 | ||
| 24 | 3 | 50 | 20 | 30 | 14.7 | 42.1 | 36.0 | 7.0 | 1.5 | 0.67∶1 | ||
| 25 | 4 | 25 | 23 | 2 | 14.6 | 42.6 | 35.6 | 7.2 | 1.0 | 11.5∶1 | ||
| 26 | 3.3 | 30 | 27.27 | 2.73 | 14.5 | 42.6 | 35.8 | 7.0 | 1.0 | 10.0∶1 | ||
| 27 | 4 | 3.3 | 30 | 27.6 | 2.4 | 14.5 | 42.6 | 35.8 | 7.0 | 1.0 | 11.5∶1 | |
| 28 | 2 | 50 | 46 | 4 | 14.3 | 42.5 | 36.2 | 7.0 | 1.0 | 11.5∶1 | ||
| 29 | 4 | 70 | 64.4 | 5.6 | 14.2 | 42.4 | 36.4 | 6.9 | 1.0 | 11.5∶1 | ||
| 30 | 4 | 30 | 22.73 | 2.27 | 14.3 | 42.1 | 35.8 | 7.7 | 1.0 | 11.5∶1 | ||
| 31 | 3.3 | 30 | 27.6 | 2.4 | 14.2 | 42.2 | 36.0 | 7.4 | 1.0 | 11.5∶1 | ||
| 32 | 4 | 50 | 46 | 4 | 14.0 | 41.8 | 36.1 | 8.0 | 1.5 | 11.5∶1 | ||
| 33 | 2.1 | 70 | 67.31 | 2.69 | 13.8 | 41.8 | 36.4 | 7.9 | 1.5 | 25.0∶1 | ||
| 34 | 6 | 25 | 23 | 2 | 15.5 | 42.1 | 34.6 | 7.7 | 1.5 | 11.5∶1 | ||
| 35 | 5 | 30 | 27.6 | 2.4 | 15.5 | 42.1 | 34.9 | 7.4 | 1.5 | 11.5∶1 | ||
| 36 | 4 | 50 | 46 | 4 | 16.2 | 43.2 | 35.2 | 7.8 | 2.0 | 11.5∶1 | ||
| 37 | 1.4 | 70 | 64.4 | 5.6 | 15.0 | 42.0 | 36.1 | 6.7 | 1.0 | 11.5∶1 | ||
| 38 | 4 | 25 | 23 | 2 | 15.2 | 41.8 | 35.6 | 7.2 | 1.0 | 11.5∶1 | ||
| 39 | 3.3 | 30 | 27.6 | 2.4 | 15.2 | 41.8 | 35.8 | 7.0 | 1.0 | 11.5∶1 | ||
| 40 | 4 | 2 | 50 | 46 | 4 | 14.9 | 41.7 | 36.4 | 6.9 | 1.0 | 11.5∶1 | |
Table 6, embodiment admix oily fish oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)-continuous 2
| Embodiment | Alloyd oil (addition and percentage composition) | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
| Fish oil | Polyenoid fish oil (fatty acid triglycercide type) | Polyenoid fish oil (fatty-acid ethyl ester type) | Composition | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||
| Percent of total | DHA percentage | EPA percentage | DHA+EPA | DHA/EPA | ||||||||
| 41 | 1.4 | 70 | 64.4 | 5.6 | 14.8 | 41.6 | 36.4 | 6.9 | 1.0 | 11.5∶1 | ||
| 42 | 4 | 25 | 23 | 2 | 16.3 | 42.5 | 33.6 | 7.3 | 1.0 | 11.5∶1 | ||
| 43 | 3.3 | 30 | 27.6 | 2.4 | 16.2 | 42.5 | 33.8 | 7.1 | 1.0 | 11.5∶1 | ||
| 44 | 4 | 50 | 46 | 4 | 16.3 | 42.5 | 33.6 | 7.3 | 2.0 | 11.5∶1 | ||
| 45 | 1.4 | 70 | 64.4 | 5.6 | 16.3 | 42.5 | 33.6 | 7.3 | 1.0 | 11.5∶1 | ||
| 46 | 5 | 30 | 27.6 | 2.4 | 15.7 | 42.0 | 34.7 | 7.8 | 1.5 | 11.5∶1 | ||
| 47 | 5 | 50 | 46 | 4 | 15.4 | 41.4 | 34.3 | 8.8 | 2.5 | 11.5∶1 | ||
| 48 | 1.4 | 70 | 64.4 | 5.6 | 15.4 | 41.7 | 35.6 | 7.1 | 1.0 | 11.5∶1 | ||
| 49 | 4 | 25 | 21 | 4 | 13.6 | 43.4 | 35.1 | 8.1 | 1.0 | 5.25∶1 | ||
| 50 | 3.3 | 30 | 25.2 | 4.8 | 13.6 | 43.4 | 35.4 | 7.6 | 1.0 | 5.25∶1 | ||
| 51 | 2 | 50 | 42 | 8 | 13.4 | 43.3 | 35.8 | 7.5 | 1.0 | 5.25∶1 | ||
| 52 | 1.4 | 70 | 58.8 | 11.2 | 14.2 | 43.2 | 36.0 | 7.5 | 1.0 | 5.25∶1 | ||
| 53 | 6 | 25 | 20 | 5 | 14.2 | 43.4 | 34.1 | 8.3 | 1.5 | 4.0∶1 | ||
| 54 | 5 | 30 | 27.27 | 2.73 | 15.2 | 44.8 | 34.5 | 8.0 | 1.5 | 10.0∶1 | ||
| 55 | 3 | 50 | 42 | 8 | 13.8 | 43.2 | 35.1 | 7.9 | 1.5 | 5.25∶1 | ||
| 56 | 2.1 | 70 | 58.8 | 11.2 | 13.6 | 43.2 | 35.4 | 7.8 | 1.5 | 5.25∶1 | ||
| 57 | 4 | 25 | 21 | 4 | 13.3 | 44.1 | 35.6 | 7.0 | 1.0 | 5.25∶1 | ||
| 58 | 3.3 | 30 | 25.2 | 4.8 | 13.2 | 44.1 | 35.8 | 6.7 | 1.0 | 5.25∶1 | ||
| 59 | 2 | 50 | 42 | 8 | 13.9 | 44.0 | 36.3 | 6.7 | 1.0 | 5.25∶1 | ||
| 60 | 5 | 30 | 25.2 | 4.8 | 13.4 | 43.8 | 35.7 | 7.1 | 1.5 | 5.25∶1 | ||
Table 6, embodiment admix oily fish oil addition and finished product ready-mixed oil aliphatic acid is formed (g/100g)-continuous 3
| Embodiment | Alloyd oil (addition and percentage composition) | Saturated fatty acid | Monounsaturated fatty acids | Omega 6 polyunsaturated fatty acid | Omega-3 polyunsaturated fatty acids | |||||||
| Fish oil | Polyenoid fish oil (fatty acid triglycercide type) | Polyenoid fish oil (fatty-acid ethyl ester type) | Composition | Total content | ω-3 long-chain polyunsaturated fatty acid | |||||||
| Percent of total | DHA percentage | The EPA proportion by subtraction | DHA+EPA | DHA/EPA | ||||||||
| 61 | 3 | 50 | 42 | 8 | 14.1 | 43.5 | 36.3 | 7.0 | 1.5 | 5.25∶1 | ||
| 62 | 2.1 | 70 | 58.8 | 11.2 | 14.0 | 43.4 | 36.6 | 7.0 | 1.5 | 5.25∶1 | ||
| 63 | 4 | 25 | 11.5 | 13.5 | 13.9 | 43.2 | 35.1 | 7.7 | 1.0 | 0.85∶1 | ||
| 64 | 3.3 | 30 | 13.8 | 16.2 | 13.9 | 43.3 | 35.4 | 7.4 | 1.0 | 0.85∶1 | ||
| 65 | 2 | 50 | 23 | 27 | 13.7 | 43.1 | 35.8 | 7.4 | 1.0 | 0.85∶1 | ||
| 66 | 1.4 | 70 | 32.2 | 37.8 | 13.6 | 43.1 | 36.0 | 7.3 | 1.0 | 0.85∶1 | ||
| 67 | 5 | 30 | 13.8 | 16.2 | 12.9 | 44.4 | 36.4 | 7.9 | 1.5 | 0.85∶1 | ||
| 68 | 3 | 50 | 23 | 27 | 12.5 | 44.2 | 37.0 | 7.8 | 1.5 | 0.85∶1 | ||
| 69 | 2.1 | 70 | 32.2 | 37.8 | 12.4 | 44.1 | 37.3 | 7.7 | 1.5 | 0.85∶1 | ||
| 70 | 4 | 25 | 10.3 | 14.7 | 13.3 | 44.8 | 34.1 | 7.8 | 1.0 | 0.70∶1 | ||
| 71 | 3.3 | 30 | 20 | 10 | 13.2 | 44.9 | 34.4 | 7.5 | 1.0 | 2.0∶1 | ||
| 72 | 2 | 50 | 23 | 27 | 13.0 | 44.7 | 34.8 | 7.5 | 1.0 | 0.85∶1 | ||
| 73 | 2.1 | 70 | 32.2 | 37.8 | 12.8 | 44.5 | 34.7 | 8.0 | 1.5 | 0.85∶1 | ||
| 74 | 3.3 | 30 | 13.8 | 16.2 | 13.6 | 44.5 | 34.5 | 7.1 | 1.0 | 0.85∶1 | ||
| 75 | 2 | 50 | 23 | 23 | 13.4 | 44.3 | 36.0 | 7.1 | 1.0 | 0.85∶1 | ||
| 76 | 2.1 | 70 | 32.2 | 37.8 | 13.2 | 44.1 | 34.9 | 7.6 | 1.5 | 0.85∶1 | ||
Claims (10)
1. nutrient blend oil, it is characterized in that: it is to add fish oil or polyenoid fish oil and make in vegetable fat, the addition of described fish oil or polyenoid fish oil is to decide according to the total content of its contained ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA), be 0.1～5.0g modulation by containing ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) total amount in every 100g finished product ready-mixed oil behind interpolation fish oil or the polyenoid fish oil promptly, described ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) is the combination of DHA (DHA) and eicosapentaenoic acid (EPA).
2. nutrient blend oil according to claim 1, it is characterized in that: described vegetable fat consists of in the two low rapeseed oils of refine peanut oil, refining sunflower oil, refining, purified soyabean oil, refined sesame oil, refining linseed oil, refined maize's oil, refining Purple Perilla Seed Oil, refining walnut oil, refining tea-seed oil, refining safflower seed oil, the refined olive oil four or more combination, and the incorporation in the finished product ready-mixed oil of every 100g is:
Its weight ratio is:
Refine peanut oil 19～44g refining sunflower oil 0～27g
The two low rapeseed oil 0～40g purified soyabean oil 0～35g of refining
Refined sesame oil 0～5g refining linseed oil 0～10.7g
Oil 0～the 28g of refined maize refining Purple Perilla Seed Oil 0～8g
Refining walnut oil 0～5g refining tea-seed oil 0～24g
Refining safflower seed oil 0～5g refined olive oil 0～8g.
3. nutrient blend oil according to claim 2 is characterized in that: described DHA (DHA) is DHA: EPA=4 with eicosapentaenoic acid (EPA) weight ratio R: 1～10: 1.
4. nutrient blend oil according to claim 2 is characterized in that: described DHA (DHA) is DHA: EPA=10 with the weight ratio R of eicosapentaenoic acid (EPA): 1～25: 1.
5. nutrient blend oil according to claim 2 is characterized in that: the weight ratio R of described DHA (DHA), eicosapentaenoic acid (EPA) is DHA: EPA=0.7: 1～2: 1.
6. nutrient blend oil according to claim 2, it is characterized in that: the weight ratio R of described DHA (DHA) and eicosapentaenoic acid (EPA) is DHA: EPA=0.25: 1～0.7: 1, and described vegetable fat consists of in refine peanut oil, refining sunflower oil, purified soyabean oil, refined sesame oil, refining linseed oil, refined maize's oil, refining Purple Perilla Seed Oil, refining walnut oil, refining tea-seed oil, refining safflower seed oil, the refined olive oil four or more above combination.
7. according to each described nutrient blend oil of claim 3～6, it is characterized in that: added antioxidant in the described vegetable fat, described antioxidant is one or both the combination in fat-soluble tea polyphenol and the vitamin E.
8. nutrient blend oil according to claim 7 is characterized in that: described antioxidant is a fat-soluble tea polyphenol, and addition is to contain 0.002～0.03g in every 100g finished product ready-mixed oil.
9. nutrient blend oil according to claim 7 is characterized in that: described antioxidant is a vitamin E, and addition is to contain 0.01～0.2g in every 100g finished product ready-mixed oil.
10. the production method of a nutrient blend oil is characterized in that comprising the steps:
(1) selected needed raw material edible oil;
(2) according to the total amount of finished product ready-mixed oil required ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) and the fish oil or the polyenoid fish oil of the selected required interpolation of the requirement of the weight ratio between DHA, the EPA thereof;
(3) calculate fish oil or the addition of polyenoid fish oil and the weight ratio between DHA, the EPA thereof according to following relational expression:
ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) weight (W) with the relational expression of fish oil or polyenoid fish oil addition is in per 100 gram finished product ready-mixed oils
W＝Wc×Xc
DHA and EPA weight ratio relational expression are in ω in the finished product ready-mixed oil-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) DHA and EPA weight ratio (R) and fish oil or the polyenoid fish oil
R＝X
DHA/X
EPA＝X
DHAc/X
EPAc
The relational expression that ω-3 long-chain polyunsaturated fatty acid in fish oil or the polyenoid fish oil (ω-3 LCPUFA) total amount, DHA, EPA weight account for its percentage by weight is
Xc＝X
DHAc+X
EPAc
In the above-mentioned relation formula:
W is ω-3 long-chain polyunsaturated fatty acid (ω-3 a LCPUFA) weight in per 100 gram finished product ready-mixed oils, and its weight range is 0.1～5.0g;
Wc be add in per 100 gram finished product ready-mixed oils fish oil or polyenoid fish oil weight; Xc accounts for the percentage of its weight for ω-3 long-chain polyunsaturated fatty acid (ω-3 LCPUFA) total amount in the fish oil that adds or the polyenoid fish oil;
X
DHA, X
EPBe respectively DHA in the finished product ready-mixed oil, EPA weight accounts for its percentage by weight; X
DHAa, X
EPAaBe respectively DHA in the seal oil, EPA weight accounts for its percentage by weight.
(4) according to containing saturated fatty acid (SFA) 12～18g in the 100 gram finished product ready-mixed oils, monounsaturated fatty acids (MUFA) 39～46g, omega 6 polyunsaturated fatty acid (ω-6 PUFA) 31～38g, the requirement of omega-3 polyunsaturated fatty acids (ω-3 PUFA) 5～9g, fish oil or polyenoid fish oil according to required interpolation, saturated aliphatic acid (SFA) in the various raw material edible oils, monounsaturated fatty acids (MUFA), omega 6 polyunsaturated fatty acid (ω-6 PUFA), omega-3 polyunsaturated fatty acids (ω-3 LCPUFA) percentage composition is calculated the portion that all kinds of raw material edible oils should add.
(5) get the fish oil that calculates portion or the antioxidant of polyenoid fish oil, raw material edible oil and ormal weight, add in the material-compound tank, holding temperature is at 20～40 ℃, is stirred at a slow speed to mix, and filters, and promptly gets the ready-mixed oil finished product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100357964A CN101142947A (en) | 2007-09-24 | 2007-09-24 | Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA2007100357964A CN101142947A (en) | 2007-09-24 | 2007-09-24 | Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101142947A true CN101142947A (en) | 2008-03-19 |
Family
ID=39205814
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA2007100357964A Pending CN101142947A (en) | 2007-09-24 | 2007-09-24 | Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101142947A (en) |
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010365A1 (en) * | 2008-07-24 | 2010-01-28 | Pharma Marine As | Polyunsaturated fatty acids for improving vision |
| CN101822294A (en) * | 2010-04-10 | 2010-09-08 | 邯郸市天养生物科技有限公司 | Walnut oil added with timnodonic acid (EPA) and preparation method thereof |
| CN101822295A (en) * | 2010-05-06 | 2010-09-08 | 丰益(上海)生物技术研发中心有限公司 | Blend oil with balanced fatty acid and production method thereof |
| WO2010149815A1 (en) * | 2009-06-26 | 2010-12-29 | Olifarma, S.L. | Olive-oil-based functional oils |
| CN102028048A (en) * | 2010-11-26 | 2011-04-27 | 中粮北海粮油工业（天津）有限公司 | Deep sea fish oil edible blend oil rich in polyunsaturated fatty acid |
| CN102232429A (en) * | 2010-05-06 | 2011-11-09 | 张瑞新 | Novel health care oil |
| CN101766238B (en) * | 2009-12-31 | 2012-04-25 | 山东三星玉米产业科技有限公司 | DHA-based corn oil for children only and method for preparing the same |
| CN101731373B (en) * | 2009-12-31 | 2012-05-30 | 山东三星玉米产业科技有限公司 | DHA-containing corn oil special for pregnant and nursing women and preparation method thereof |
| WO2012150582A1 (en) * | 2011-05-04 | 2012-11-08 | Shemen Industries Ltd | Edible oil for seniors |
| CN102813011A (en) * | 2012-08-08 | 2012-12-12 | 辽宁省大连海洋渔业集团公司 | Edible oil for reinforcing antioxidation function |
| CN103392836A (en) * | 2013-07-09 | 2013-11-20 | 菏泽市牡丹区牡丹研究所 | Peony seed oil natural antioxidant composite |
| CN103602516A (en) * | 2013-11-13 | 2014-02-26 | 王玉清 | Natural vegetable oil containing rich n-3 unsaturated fatty acids and preparation method thereof |
| CN103859061A (en) * | 2012-12-18 | 2014-06-18 | 山东西王食品有限公司 | Plant blend oil with balanced n-3, n-6 and n-9 series fatty acids |
| CN105123999A (en) * | 2015-09-24 | 2015-12-09 | 全椒县尹氏油脂有限公司 | Health edible oil for pregnant women |
| CN106922847A (en) * | 2017-04-05 | 2017-07-07 | 厦门农特康生物科技有限公司 | A kind of health care ready-mixed oil and its detection method rich in alpha linolenic acid and nervonic acid |
| CN107509822A (en) * | 2017-08-25 | 2017-12-26 | 山东鲁派国际食品有限公司 | A kind of special edible oil of pregnant woman and preparation method thereof |
| CN108041184A (en) * | 2017-12-20 | 2018-05-18 | 山东朱氏药业集团有限公司 | A kind of compound lard for preventing and treating angiocardiopathy |
| CN108244272A (en) * | 2018-03-15 | 2018-07-06 | 北京诺康达医药科技有限公司 | It is a kind of for fat or oil composition of various disease crowd and preparation method thereof |
| CN112057444A (en) * | 2020-09-17 | 2020-12-11 | 温州医科大学 | Application of scleral lipid metabolism pathway intervention regulator or lipid metabolism regulating drug as drug for inhibiting myopia negative phototropism and prolonging axis of eyes |
| CN113615745A (en) * | 2021-08-19 | 2021-11-09 | 桦南农盛园食品有限公司 | Blending method of nutrition supplementing blend oil and product |
| CN113789213A (en) * | 2021-09-30 | 2021-12-14 | 重庆市云阳县亿果香林业有限公司 | Preparation method of Chinese torreya oil |
-
2007
- 2007-09-24 CN CNA2007100357964A patent/CN101142947A/en active Pending
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010010365A1 (en) * | 2008-07-24 | 2010-01-28 | Pharma Marine As | Polyunsaturated fatty acids for improving vision |
| WO2010149815A1 (en) * | 2009-06-26 | 2010-12-29 | Olifarma, S.L. | Olive-oil-based functional oils |
| ES2351141A1 (en) * | 2009-06-26 | 2011-02-01 | Olifarma, S.L. | Olive-oil-based functional oils |
| CN101766238B (en) * | 2009-12-31 | 2012-04-25 | 山东三星玉米产业科技有限公司 | DHA-based corn oil for children only and method for preparing the same |
| CN101731373B (en) * | 2009-12-31 | 2012-05-30 | 山东三星玉米产业科技有限公司 | DHA-containing corn oil special for pregnant and nursing women and preparation method thereof |
| CN101822294A (en) * | 2010-04-10 | 2010-09-08 | 邯郸市天养生物科技有限公司 | Walnut oil added with timnodonic acid (EPA) and preparation method thereof |
| CN101822295B (en) * | 2010-05-06 | 2013-07-31 | 丰益(上海)生物技术研发中心有限公司 | Blend oil with balanced fatty acid and production method thereof |
| CN101822295A (en) * | 2010-05-06 | 2010-09-08 | 丰益(上海)生物技术研发中心有限公司 | Blend oil with balanced fatty acid and production method thereof |
| CN102232429A (en) * | 2010-05-06 | 2011-11-09 | 张瑞新 | Novel health care oil |
| CN102028048A (en) * | 2010-11-26 | 2011-04-27 | 中粮北海粮油工业（天津）有限公司 | Deep sea fish oil edible blend oil rich in polyunsaturated fatty acid |
| WO2012150582A1 (en) * | 2011-05-04 | 2012-11-08 | Shemen Industries Ltd | Edible oil for seniors |
| CN102813011A (en) * | 2012-08-08 | 2012-12-12 | 辽宁省大连海洋渔业集团公司 | Edible oil for reinforcing antioxidation function |
| CN103859061A (en) * | 2012-12-18 | 2014-06-18 | 山东西王食品有限公司 | Plant blend oil with balanced n-3, n-6 and n-9 series fatty acids |
| CN103392836A (en) * | 2013-07-09 | 2013-11-20 | 菏泽市牡丹区牡丹研究所 | Peony seed oil natural antioxidant composite |
| CN103602516A (en) * | 2013-11-13 | 2014-02-26 | 王玉清 | Natural vegetable oil containing rich n-3 unsaturated fatty acids and preparation method thereof |
| CN105123999A (en) * | 2015-09-24 | 2015-12-09 | 全椒县尹氏油脂有限公司 | Health edible oil for pregnant women |
| CN106922847A (en) * | 2017-04-05 | 2017-07-07 | 厦门农特康生物科技有限公司 | A kind of health care ready-mixed oil and its detection method rich in alpha linolenic acid and nervonic acid |
| CN107509822A (en) * | 2017-08-25 | 2017-12-26 | 山东鲁派国际食品有限公司 | A kind of special edible oil of pregnant woman and preparation method thereof |
| CN108041184A (en) * | 2017-12-20 | 2018-05-18 | 山东朱氏药业集团有限公司 | A kind of compound lard for preventing and treating angiocardiopathy |
| CN108244272A (en) * | 2018-03-15 | 2018-07-06 | 北京诺康达医药科技有限公司 | It is a kind of for fat or oil composition of various disease crowd and preparation method thereof |
| CN112057444A (en) * | 2020-09-17 | 2020-12-11 | 温州医科大学 | Application of scleral lipid metabolism pathway intervention regulator or lipid metabolism regulating drug as drug for inhibiting myopia negative phototropism and prolonging axis of eyes |
| CN113615745A (en) * | 2021-08-19 | 2021-11-09 | 桦南农盛园食品有限公司 | Blending method of nutrition supplementing blend oil and product |
| CN113789213A (en) * | 2021-09-30 | 2021-12-14 | 重庆市云阳县亿果香林业有限公司 | Preparation method of Chinese torreya oil |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100542411C (en) | A kind of nutrition balanced mixed oil and production method thereof that contains omega-3 polyunsaturated fatty acids | |
| CN100521953C (en) | Nutrition balanced mixed oil containing algal oil and producing method thereof | |
| CN101142947A (en) | Nutrition balanced mixed oil containing fish-oil or polyenoid fish-oil and its production method | |
| JP4642087B2 (en) | Food compounding agent comprising arachidonic acid-containing edible oil and fat derived from microorganisms, food containing the same, and method for producing arachidonic acid-containing edible oil and fat | |
| CN101720822A (en) | Nutritional blend oil with balanced fatty acid component and active component for middle and old aged | |
| US5686131A (en) | Edible oil or fat and edible oil or fat mixture | |
| CN104719510A (en) | Pregnant woman and infant nutritional tea oil containing DHA and AA | |
| CN101810226A (en) | Fatty acid component balanced children type nutrition blended oil containing multiple active ingredients | |
| CN108402188A (en) | A kind of edible oil and preparation method for strengthening supplement DHA and alpha-linolenic acid | |
| CN101617721A (en) | Balanced-nutrition healthy edible blend oil with brain tonic efficacy | |
| CN102894107A (en) | Nutritional walnut oil and production process thereof | |
| CN101088349B (en) | Edible blend oil containing docosahexenoic acid | |
| CN101755927A (en) | Edible fortified tea oil for pregnant woman and preparation method thereof | |
| CN1927050B (en) | DHA microcapsule food additives, DHA soft capsule health product and uses thereof | |
| CN106615178A (en) | Solid DHA (docosahexaenoic acid) algae oil beverage | |
| CN104322712A (en) | Linseed oil stabilization emulsion and preparation method thereof | |
| CN100508769C (en) | Nutrition balanced mixed oil containing seal oil and production method thereof | |
| CN102028048A (en) | Deep sea fish oil edible blend oil rich in polyunsaturated fatty acid | |
| CN101756299B (en) | Undaria pinnatifida with perilla plum flavor and preparation method thereof | |
| CN103518867A (en) | Natural cereal blend oil | |
| CN105010576A (en) | A stable flaxseed oil emulsion and a preparation method thereof | |
| CN106343045A (en) | Nutrient enrichment functional low-temperature edible blend grease containing enriched in long carbon chain polyunsaturated fatty acid lipoids | |
| CN103416729A (en) | Mayonnaise rich in alpha-linolenic acid | |
| CN101700080A (en) | Edible oil for specially supplementing alpha-linolenic acid nutrient | |
| CN110200085A (en) | A kind of sunflower seeds nutrient blend oil and preparation method thereof suitable for pregnant woman |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |